Company: IXHL
Filing Date: 2025-02-14
Form Type: 10-Q
Source: 0001213900-25-013783
Chunk: 1

Company: Incannex Healthcare Inc.
Filing Date: 2025-02-14
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
4 respectively 
     2  
     2 
  
    Preferred stock, $0.0001 par value per share, 10,000,000 shares authorized; no shares issued or outstanding at December 31, 2024 and June 30, 2024, respectively 
     -  
     - 
  
    Additional paid-in capital 
     126,354  
     125,218 
  
    Accumulated deficit 
     (121,984) 
     (110,671)
  
    Foreign currency translation reserve 
     (3,407) 
     (3,332)
  
    Total stockholders’ equity 
     965  
     11,217 
  
    Total liabilities and stockholders’ equity 
    $11,106  
    $17,047 

The accompanying notes are an integral part of
these condensed consolidated financial statements.

1

INCANNEX HEALTHCARE INC.

Condensed Consolidated Statements of Operations
and Comprehensive Loss

(unaudited)

(in thousands, except share and per share amounts)

(expressed
in U.S. Dollars, unless otherwise stated)

    For the three months ended December 31,  
    For the six months ended December 31, 

    2024  
    2023  
    2024  
    2023 
  
    Revenue from customers 
     12  
     -  
     86  
     - 
  
    Operating expenses: 

    Research and development 
     (1,414) 
     (2,638) 
     (4,310) 
     (5,247)
  
    General and administrative 
     (3,602) 
     (5,345) 
     (7,034) 
     (7,629)
  
    Total operating expenses 
     (5,016) 
     (7,983) 
     (11,344) 
     (12,876)
  
    Loss from operations 
     (5,004) 
     (7,983) 
     (11,258) 
     (12,876)
  
    Other income, net: 
        
     -  
        
     - 
  
    R&D tax incentive 
     956  
     2,727  
     1,767